Company Overview
Snapshot
Founded in February 2021 by Avi Domb, Nexocarp operates with 1–10 employees. The company has secured Seed funding from Racah Nano Venture Fund in February 2021.
Business overview
Nexocarp develops novel, sustainable microencapsulation solutions, primarily focusing on all-natural microencapsulation products. The company's technology, developed at the Hebrew University of Jerusalem, serves leading players in industries such as cosmetics, agrochemicals, food, and pharmaceuticals. Nexocarp operates within the Health Tech & Life Sciences sector, with applications in Pharma & Medical Biotechnology and Drugs Discovery & Development, as well as Climate Tech, specifically in Sustainable Materials & Circularity.
Log in to access full profile ›Company Intelligence Q&A
- What is Nexocarp's primary focus?
- Nexocarp focuses on developing and offering novel, sustainable microencapsulation solutions, particularly all-natural products, for leading players in industries such as cosmetics, agrochemicals, food, and pharmaceuticals.
- When was Nexocarp founded?
- Nexocarp was founded in February 2021.
- Who is a key founder of Nexocarp?
- Avi Domb is a co-founder and CTO of Nexocarp.
- What is the origin of Nexocarp's core technology?
- Nexocarp's encapsulation method is based on proprietary technology developed at the Hebrew University of Jerusalem.
- Which investor participated in Nexocarp's Seed funding round?
- In February 2021, Nexocarp received Seed funding from Racah Nano Venture Fund.